|
Socio-demographic
|
Sex (female = 1)
|
0.97
|
0.95–0.99
|
<.0003
|
0.78
|
0.76–0.81
|
<.0003
|
|
Higher SES
|
0.97
|
0.97–0.98
|
<.0001
|
0.98
|
0.97–0.98
|
<.0001
|
|
Year
|
0.99
|
0.98–1.00
|
<.0001
|
0.96
|
0.96–0.97
|
<.0001
|
|
Age
|
0.81
|
0.81–0.82
|
<.0001
|
0.9
|
0.89–0.91
|
<.0001
|
|
Asthma treatment variables
|
Asthma-related hospitalization
|
1.63
|
1.51–1.76
|
<.0001
|
0.99
|
0.83–01.18
|
0.9222
|
|
Asthma-related outpatient visit
|
0.95
|
0.94–0.96
|
<.0001
|
0.89
|
0.88–0.91
|
<.0001
|
|
Oral corticosteroid
|
1.28
|
1.25–1.30
|
<.0001
|
0.4
|
0.38–0.41
|
<.0001
|
|
Severity of Asthma
|
1.18
|
1.16–1.20
|
<.0001
|
3.6
|
3.52–3.69
|
<.0001
|
|
Comorbidity-related variables
|
Modified Charlson score
|
1.11
|
1.09–1.12
|
<.0001
|
0.98
|
0.96–1.00
|
0.1033
|
|
None asthma related hospitalization
|
1.01
|
1.00–1.02
|
0.0009
|
1.01
|
1.00–1.03
|
0.0789
|
|
None asthma related outpatient visit
|
1.00
|
1.00–1.00
|
<.0001
|
1.00
|
1.00–1.00
|
0.0137
|
|
Type & quality of care
|
Having received pulmonary function test
|
0.95
|
0.92–0.97
|
<.0003
|
0.87
|
0.82–0.92
|
<.0001
|
|
Respirologist consultation
|
0.57
|
0.54–0.59
|
<.0001
|
0.54
|
049–0.60
|
<.0001
|
|
Internal medicine consultation
|
0.98
|
0.93–1.03
|
0.5501
|
0.74
|
0.67–0.81
|
0.0014
|
|
General Practitioner Asthma visit
|
0.67
|
0.66–0.68
|
<.0001
|
1.16
|
1.12–1.19
|
<.0001
|
|
Continuity of care (COC)
| | | | | | |
|
COC = 0
|
–
|
–
|
–
| |
–
|
–
|
|
COC > 0 and COC < 50%
|
0.84
|
0.82–0.86
|
<.0001
|
0.76
|
0.74–0.79
|
<.0001
|
|
COC > =50% and OC < 100%
|
0.86
|
0.84–0.88
|
<.0001
|
0.84
|
0.80–0.88
|
0.0014
|
|
COC = 100%
|
0.86
|
0.83–0.83
|
<.0001
|
0.85
|
0.80–0.90
|
<.0001
|
